SCHEMBL7577574

SCHEMBL7577574

O=C(O)C(Nc1cc(Cl)ccc1Cl)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CXCL8 P10145 1/20 0.47
CYP2C9 P11712 1/20 0.47
POLB P06746 1/20 0.46
EPHX1 P07099 1/20 0.46
GRIK1 P39086 1/20 0.44
ALDH1A1 P00352 2/20 0.43
PSMB5 P28074 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
PKM P14618 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7583928 0.88 TAS1R3 (0.51) MEN1KMT2AL3MBTL1HTTCA1
SCHEMBL7582482 0.86 CA1 (0.46) MEN1KMT2ACA1CA2ALDH1A1
SCHEMBL7575575 0.86 KCNMA1 (0.54) MEN1KMT2AMAPK1HTTPOLB
SCHEMBL6244215 0.83 KCNQ2 (0.53) MEN1KMT2AL3MBTL1MAPK1HTT
SCHEMBL7577550 0.82 PPARG (0.51) MEN1KMT2AL3MBTL1POLBGRIK1
SCHEMBL7576195 0.81 TDP1 (0.51) MEN1KMT2ACA1CA2POLB
SCHEMBL7573328 0.81 ALDH1A1 (0.63) MEN1KMT2AL3MBTL1HTTPOLB
SCHEMBL7584703 0.78 NPC1 (0.53) MEN1KMT2ACA1CA2EPHX1
SCHEMBL7574221 0.78 ALDH1A1 (0.44) MEN1KMT2ACA1CA2ALDH1A1
SCHEMBL1696047 0.77 MDM2 (0.48) MEN1KMT2ACA1CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2002-09-25 EP disclosed
WO-2001003684-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2001-01-18 WO disclosed